TIMD4 and neoplasm: TIM-4 on tumor-associated myeloid cells directly interacts with adenosine monophosphate activating kinase-α1(AMPKα1) to activate autophagy-mediated degradation of ingested tumors, resulting in reduced antigen presentation and impaired cytotoxic T lymphocyte (CTL) response.